CLINICAL_TRIALS
trial_result
· 2012-10-11
Clinical Trial Update: A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase II study evaluating oral ONO-5129 in Type 2 diabetes mellitus; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharma USA Inc | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED